Status:
COMPLETED
Pulmonary Vein Diameter and Collapsibility Measured by TEE to Predict Elevated Left Atrial Pressure in Cardiac Surgery
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Elevated Left Atrial Pressure
Eligibility:
All Genders
18+ years
Brief Summary
Left atrial pressure (LAP) is a crucial hemodynamic parameter during cardiac surgery. Elevated LAP leads to pulmonary edema and other cardiopulmonary complications. The pulmonary capillary wedge press...
Detailed Description
The evaluation of left ventricle filling pressures (LVFP) perioperatively in cardiac surgery could be challenging. This is particularly relevant after separation from cardiopulmonary bypass because th...
Eligibility Criteria
Inclusion
- Patients aged of 18 years or more,
- Scheduled for an elective cardiac surgery at the Montpellier University Hospital,
- Requiring a pulmonary arterial catheter monitoring due to the complexity of cardiac surgery or severe cardiopulmonary comorbidities.
Exclusion
- Failure of the pulmonary artery catheterization,
- Failure of PCWP measurement,
- Failure of TEE measure of the left upper pulmonary vein diameter and collapsibility,
- Refusal to participate expressed secondarily.
- Non-inclusion criteria :
- Cardiac transplantation,
- Left ventricule assist device,
- Pulmonary vein stenosis,
- Contraindications to TEE or PAC,
- Refusal to participate,
- Patient under juridical protection
Key Trial Info
Start Date :
August 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 20 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04096807
Start Date
August 8 2019
End Date
September 20 2021
Last Update
October 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295